Gyeonggi-do, South Korea

Wenling Song

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: J2h Biotech Inc.. Active years: 2022-2024.

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Gyeonggi-do, KR (2022)
  • Uiwang-Si, KR (2024)

Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Wenling Song: Innovator in Pharmaceutical Advancements

Introduction

Wenling Song is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of non-alcoholic steatohepatitis and muscular dystrophy. With a total of 2 patents, his work reflects a commitment to advancing medical science.

Latest Patents

Wenling Song's latest patents include a pharmaceutical composition aimed at preventing or treating non-alcoholic steatohepatitis (NASH) and hepatic fibrosis. This invention focuses on the medical use of a specific compound, identified as Chemical Formula 1, which has shown promise in alleviating these conditions. Additionally, he has developed compounds useful for the treatment or prevention of muscular dystrophy. This patent highlights a novel compound that is particularly beneficial for treating Duchenne muscular atrophy, showcasing his innovative approach to medicinal use.

Career Highlights

Wenling Song is associated with J2H Biotech Inc., where he continues to push the boundaries of pharmaceutical research. His work is characterized by a strong focus on developing effective treatments for serious health conditions, demonstrating his dedication to improving patient outcomes.

Collaborations

Wenling collaborates with esteemed colleagues, including Jae-Sun Kim and Jee-Woong Lim. These partnerships enhance the research environment and contribute to the innovative solutions being developed at J2H Biotech Inc.

Conclusion

Wenling Song's contributions to pharmaceutical innovation are noteworthy, particularly in the areas of non-alcoholic steatohepatitis and muscular dystrophy. His patents reflect a deep understanding of medical needs and a commitment to finding effective treatments. Through his work, he continues to make a significant impact in the field of medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…